Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38"

Robert S. Rosenstein; David Parra

doi:10.1161/CIRCULATIONAHA.108.829838

Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38"

Robert S. Rosenstein, David Parra

Medicine

Research output: Contribution to journal › Letter

Original language	English (US)
Pages (from-to)	e601
Journal	Circulation
Volume	119
Issue number	25
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.108.829838
State	Published - Jun 30 2009

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.108.829838

Cite this

Rosenstein, R. S., & Parra, D. (2009). Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38". Circulation, 119(25), e601. https://doi.org/10.1161/CIRCULATIONAHA.108.829838

Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel : Thrombolysis in myocardial infarction 38". / Rosenstein, Robert S.; Parra, David.

In: Circulation, Vol. 119, No. 25, 30.06.2009, p. e601.

Research output: Contribution to journal › Letter

Rosenstein, RS & Parra, D 2009, 'Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38"', Circulation, vol. 119, no. 25, pp. e601. https://doi.org/10.1161/CIRCULATIONAHA.108.829838

Rosenstein RS, Parra D. Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38". Circulation. 2009 Jun 30;119(25):e601. https://doi.org/10.1161/CIRCULATIONAHA.108.829838

Rosenstein, Robert S. ; Parra, David. / Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel : Thrombolysis in myocardial infarction 38". In: Circulation. 2009 ; Vol. 119, No. 25. pp. e601.

@article{baba678796a546b3a9f957d0900f8c63,

title = "Letter by rosenstein and parra regarding article, {"}greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38{"}",

author = "Rosenstein, {Robert S.} and David Parra",

year = "2009",

month = jun,

day = "30",

doi = "10.1161/CIRCULATIONAHA.108.829838",

language = "English (US)",

volume = "119",

pages = "e601",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "25",

}

TY - JOUR

T1 - Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel

T2 - Thrombolysis in myocardial infarction 38"

AU - Rosenstein, Robert S.

AU - Parra, David

PY - 2009/6/30

Y1 - 2009/6/30

UR - http://www.scopus.com/inward/record.url?scp=67650727967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650727967&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.829838

DO - 10.1161/CIRCULATIONAHA.108.829838

M3 - Letter

C2 - 19564566

AN - SCOPUS:67650727967

VL - 119

SP - e601

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 25

ER -